文献速递乳腺癌

丹麦人群研究:乳腺导管原位癌中前哨淋巴结活检的使用

The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
PubMed 文献 · Eur J Cancer · 2017-10-27

该研究基于丹麦乳腺癌协作组数据库,纳入2004–2015年确诊的2618例乳腺导管原位癌(DCIS)女性患者,评估前哨淋巴结活检(SLNB)的使用情况。结果显示54.3%的患者接受了SLNB,使用率从2004年的26.6%升至2015年的65.1%,且各外科科室间依从国家指南程度差异显著。

要点

  • DCIS患者SLNB使用率呈明显上升趋势,2004年为26.6%,2015年达65.1%。
  • 指南未覆盖的454例患者中仍有23.8%接受了SLNB,提示存在过度分期。
  • 保乳手术联合SLNB的比例在各科室间差异显著,范围为19.7%至63.8%。

核心结论

  • DCIS患者中SLNB的使用及对丹麦国家指南的依从性在各乳腺外科科室间存在差异,需提高指南依从性以优化腋窝处理。

研究设计与样本

  • 基于丹麦乳腺癌协作组数据库的登记研究,纳入2004–2015年确诊DCIS的2618例丹麦女性患者。
  • 按诊断年份、诊断年龄、病灶大小、Van Nuys分类、可触及性、位置及手术科室评估SLNB使用情况,组间差异采用卡方检验。

主要发现

  • 54.3%的患者接受了SLNB,使用率从2004年的26.6%上升至2015年的65.1%。
  • 1877例(71.7%)行保乳手术,其中43.9%同期行SLNB;577例(22.0%)行乳房切除术,其中86.0%同期行SLNB。
  • 指南未覆盖的454例患者中23.8%接受了SLNB。
  • 保乳手术联合SLNB的比例在各科室间差异显著,范围为19.7%至63.8%。
  • 按科室容量(高容量与低容量)比较,保乳及乳房切除术中SLNB的使用存在显著差异。

临床怎么用

  • DCIS患者应依据现行指南选择性使用SLNB,避免过度治疗与不必要的并发症。
  • 科室层面需加强国家DCIS指南的依从性,减少机构间实践差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The risk of axillary metastases in breast cancer patients with only ductal carcinoma in situ (DCIS) is low. Thus, axillary staging with sentinel lymph node biopsy (SLNB) should only be used according to the current guidelines to avoid over-treatment and unnecessary morbidity. In the present study, the use of SLNB in patients with DCIS was evaluated nationally and compared across Danish departments. MATERIAL AND METHODS: A register-based study was conducted using the Danish Breast Cancer Group database. The use of SLNB in DCIS patients according to year of diagnosis, age at diagnosis, size of lesion, Van Nuys classification, palpability, location and department of surgery was evaluated. The chi-squared test was used to test differences between the groups. RESULTS: Data from 2618 Danish female patients diagnosed with DCIS between 2004 and 2015 were included; 54.3% of patients underwent SLNB. The use of SLNB increased from 26.6% in 2004 to 65.1% in 2015. A total of 1877 (71.7%) patients underwent breast-conserving surgery (BCS), and 577 (22.0%) underwent mastectomy, of which 43.9% and 86.0% respectively had a concomitant SLNB. The SLNB was performed in 23.8% of 454 patients not included by the guidelines. The use of SLNB in combination with BCS differed significantly between departments ranging from 19.7% to 63.8%. A significant difference in the use of SLNB with BCS and mastectomy according to department capacity (high-volume departments versus low-volume departments) was observed. CONCLUSION: The use of SLNB in patients with DCIS and adherence to the Danish national guidelines varies among Danish breast surgery departments. To optimise the axillary treatment of patients with DCIS, an improved compliance to the national DCIS guidelines is necessary.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Holm-Rasmussen EV, Jensen MB, Balslev E, et al. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study. Eur J Cancer. 2017. PMID: 29096155. doi:10.1016/j.ejca.2017.09.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。